Analyst Ratings for Bristol-Myers Squibb Co. (BMY)
BMY Rating Summary
BMY Price Target Summary
- Highest: $78.00 (BofA Securities)
- Lowest: $62.00 (Morgan Stanley)
- Average: $72.55
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$72.55 (+11.8%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 55%
Avg. $ Target:
$72.55 (+11.8%)
* Over Last 12-Mos
Rating Score: 5.3 / 10
Percentile Rank: 55%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2021 | Morgan Stanley | David Risinger | Downgrade | Equalweight (Overweight) |
62.00 (70.00) |
66.03 (64.88) |
-1.74% | Details |
| 4/13/2021 | Truist Securities | Gregg Gilbert | Upgrade | Buy (Hold) |
74.00 (66.00) |
62.69 (64.88) |
3.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
